Topic: Pharmaceuticals

CCI: quality concerns undermining pharmaceutical competition

A key hurdle to greater price competition for generic drugs in India is consumer concern and information asymmetry about quality, according to a market study conducted by the country’s competition watchdog.

19 November 2021

FTC conditionally approves generic pharma merger

ANI Pharmaceuticals must divest the production rights for a generic antibiotic and a generic steroid to proceed with its $210 million purchase of Novitium, the Federal Trade Commission has said.

11 November 2021

Judge Cote rejects Shkreli’s request to testify remotely at trial

Any attempt to accommodate Martin Shkreli’s request to testify at trial remotely would “significantly burden the Court, the parties and the Bureau of Prisons”, a federal New York Judge has ruled.

01 November 2021

EU watchdog upholds dawn raid surge promise

The European Commission has raided the Belgian offices of animal pharmaceutical manufacturer Zoetis, days after EU competition commissioner Margrethe Vestager warned of multiple planned inspections in the coming months.

25 October 2021

Shkreli seeks to delay December trial in FTC lawsuit

Martin Shkreli has asked a New York federal judge to postpone his monopolisation trial by at least four and a half months, after claiming that attending the proceeding in December could mean he has to spend an extra year in prison.

14 October 2021

A Q&A with Gwendolyn Cooley

Gwendolyn Cooley, Wisconsin’s top antitrust enforcer, will soon have an additional 55 state competition offices under her purview. GCR USA spoke to Cooley about what she hopes to accomplish as she takes over as the next chair of the antitrust task force for the National Association of Attorneys General (NAAG) on 26 October.

20 September 2021

States seek interviews from DOJ’s criminal case against generic pharma

A federal judge in Philadelphia has delayed making a firm decision on whether civil plaintiffs suing generic drugmakers for alleged price-fixing can access confidential interviews from the Department of Justice’s criminal case.

10 September 2021

Illumina faces EU gun-jumping probe over Grail acquisition

The European Commission has opened a gun-jumping investigation into Illumina, two days after the biotechnology company completed its acquisition of Grail in the midst of the EU’s in-depth merger review.

20 August 2021

Illumina closes Grail deal without EU approval

Illumina has closed its €5.9 billion acquisition of Grail despite an ongoing EU Phase II probe, reiterating its claims that the European Commission has no jurisdiction to review the tie-up.

19 August 2021

Mexico hits drug distributors with highest possible fine

Mexico’s competition enforcer has fined five drug distributors, an industry association and 21 executives the highest possible combined sanction of €38.5 million, while also disqualifying senior company employees for the first time in its history.

17 August 2021

Get unlimited access to all Global Competition Review content